Furosemide

AUG 17, 2026 · PHASE 3 TRIAL

ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.

ClinicalTrials.gov

This is a Phase 3 trial registration with no reported results; the study is not yet recruiting and outcome data are not posted in this registry record.

JUN 2, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Furosemide (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling changes to furosemide; regulatory action without clinical trial data or efficacy claims.